Loading patent…
AssigneeKorea Research Institute of Bioscience and Biotechnology
InventorsMun Chual Rho, Woo Song Lee, Hyun Mee Oh, Young Min Kim, Young Bae Ryu, Su Jin Park, Seung Woong Lee, Kyoung Oh Cho
Estimating the term…
The present invention relates to a pharmaceutical composition including oleanolic acid acetate or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating TLR- and IL-6-mediated diseases, and a pharmaceutical composition including an adzuki bean extract containing the compound or the salt thereof, or a fraction thereof as an active ingredient for preventing or treating TLR- and IL-6-mediated diseases. The adzuki bean extract or the compound of the present invention is derived from a natural resource that has been used as a natural medicine for a long time, and it is widely used for the development of prophylactic or therapeutic agents for TLR- and IL-6-mediated diseases, for example, atopic dermatitis or arthritis.
1-22. (canceled)
A method for treating TLR- and IL-6-mediated diseases, comprising the step of administering a pharmaceutical composition to a subject suspected of having TLR- and IL-6-mediated diseases, wherein the pharmaceutical composition comprises a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient:
A method for treating TLR- and IL-6-mediated diseases, comprising the step of administering a pharmaceutical composition to a subject suspected of having TLR- and IL-6-mediated diseases, wherein the pharmaceutical composition comprises an adzuki bean extract containing a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof, or a fraction thereof as an active ingredient:
Dependencies are inferred from the claim text.